Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events,

Soo Ting Toh1, Yu Jin, Lizhen Liu

  • 1Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Carcinogenesis
|January 2, 2013
PubMed

Insights

Hepatitis B virus (HBV) integration in hepatocellular carcinoma (HCC) tumors shows specific patterns, including preferential insertion into gene promoters and the TERT gene, potentially driving cancer development. This study reveals HBV

Area of Science:

  • Virology
  • Oncology
  • Genetics

Background:

  • Chronic hepatitis B virus (HBV) infection is linked to hepatocellular carcinoma (HCC), but the underlying mechanisms are unclear.
  • Technological limitations have hindered a comprehensive understanding of HBV's role in HCC development.

Purpose of the Study:

  • To systematically characterize HBV integration and alterations in HCC tumors.
  • To identify specific host and viral genomic regions involved in HBV integration and structural changes.

Main Methods:

  • Enrichment of HBV sequences from 48 HCC patients using an oligo-bead-based strategy.
  • High-throughput sequencing (FLX-Genome-Sequencer) of pooled HBV DNA.
  • Analysis of HBV integration sites, viral structural alterations, and gene expression (TERT).

Main Results:

  • HBV preferentially integrates into gene promoters (P < 0.001), with significant enrichment on chromosome 10 (P < 0.01).
  • Integration into chromosome 10 correlates with poorly differentiated HCC (P < 0.05).
  • Recurrent HBV integration into the TERT promoter increases TERT expression, and alterations often involve the 3'-end of the HBx gene, leading to chimeric transcripts and proteins.

Conclusions:

  • HBV exhibits high mutability and specific integration preferences in HCC.
  • HBV integration into host genes, particularly TERT, and viral structural alterations are key events in HCC pathogenesis.
  • Understanding these HBV-host interactions provides insights into HCC development and potential therapeutic targets.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...